<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>The Final Verdict is In: Celebrex Found to Increase Cardiovascular Risks</title><link>http://articles.mercola.com/sites/articles/archive/2005/03/09/celebrex-risk.aspx</link><description>When popular painkiller drug Vioxx was pulled from the market after being found to double cardiovascular risks, Pfizer, maker of the rival arthritis medicine Celebrex, took a brave step. In fact, Pfizer was so confident in their drug that they ran a 4</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>